STRO - SUTRO BIOPHARMA, INC.


21.31
1.610   7.555%

Share volume: 198,657
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.44%

PREVIOUS CLOSE
CHG
CHG%

$19.70
1.61
0.08%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Report Date 05-13-2024 08-13-2024 11-13-2024 03-13-2025 05-08-2025 08-07-2025 11-06-2025
Total revenue 13.008 M 25.706 M 8.520 M 14.809 M 17.399 M 63.745 M 9.693 M
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 13.008 M 25.706 M 8.520 M 14.809 M 17.399 M 63.745 M 9.693 M
    97.62% -66.86% 73.81% 17.49% 266.37% -84.79%  
Operating expenses 69.599 M 74.391 M 76.439 M 80.067 M 64.870 M 48.668 M 48.594 M
Selling general and admin 12.721 M 12.371 M 14.331 M 9.030 M 13.273 M 10.343 M 8.741 M
Research and development 56.878 M 62.020 M 62.108 M 71.037 M 51.597 M 38.325 M 39.853 M
Total expenses 69.599 M 74.391 M 76.439 M 80.067 M 85.913 M 67.090 M 58.152 M
    6.89% 2.75% 4.75% 7.30% -21.91% -13.32%  
Operating income -56.591 M -48.685 M -67.919 M -65.258 M -68.514 M -3.345 M -48.459 M
Ebit -56.591 M -43.877 M -67.919 M -73.745 M -68.514 M -3.345 M -48.459 M
Pretax income -58.213 M -48.010 M -48.787 M -70.088 M -75.968 M -11.517 M -56.857 M
    -17.53% 1.62% 43.66% 8.39% -84.84% 393.68%  
Income tax 0.000 8.000 K 0.000 2.355 M 0.000 -18.000 K 0.000
Net income basic -58.213 M 0.000 0.000 0.000 0.000 0.000 0.000
    100.00%            
Net income -58.213 M -48.018 M -48.787 M -72.443 M -75.968 M -11.499 M -56.857 M
    17.51% -1.60% -48.49% -4.87% 84.86% -394.45%